Influence of Exercise in Patients With Chronic Kidney Disease During Hemodialysis
Condition:   Chronic Kidney Diseases Intervention:   Other: physical exercise Sponsors:   Universidade Metodista de Piracicaba;   Universidade do Estado do Pará Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Conditions:   Anemia;   Renal Insufficiency, Chronic Intervention:   Drug: Mircera Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

Exercise on Hypertension in Chronic Kidney Disease
Condition:   Chronic Kidney Diseases Intervention:   Behavioral: Exercise Sponsors:   University of Alberta;   Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
Conditions:   Chronic Kidney Disease;   Proteinuria Interventions:   Drug: Telmisartan/Rosuvastatin 40/10mg;   Drug: Telmisartan 40mg Sponsor:   Yuhan Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
Condition:   Chronic Kidney Diseases Interventions:   Drug: Calcium Carbonate;   Drug: Placebo oral capsule Sponsors:   Indonesia University;   Dr Cipto Mangunkusumo General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population
Conditions:   Hypercholesterolemia;   Chronic Kidney Diseases Interventions:   Drug: Simvastatin 40mg;   Drug: Ezetimibe/simvastatin 10/20 mg/day;   Drug: Ezetimibe/simvastatin 10/40 mg/day Sponsors:   Hue University of Medicine and Pharmacy;   Università degli Studi di Sassari Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2018 Category: Research Source Type: clinical trials